The international network ACHILLES DN – Advancing in the Challenge of Improving Lymphoma and Leukemia Survival has officially opened applications for 16 PhD positions in experimental hemato-oncology, among which one available in the HEVA Research laboratory of professor Emanuele Azzoni at the University of Milano-Bicocca.
ACHILLES DN is a Marie Skłodowska-Curie Actions (MSCA) Doctoral Network, funded by the European Commission under the Horizon Europe programme, with the aim of training a new generation of highly skilled researchers in the field of hematological malignancies.
A high-level training programme
The programme will deliver advanced, multidisciplinary training covering the full translational research pathway — from fundamental biological discoveries to the development of innovative therapeutic strategies and diagnostic tools for leukemia and lymphoma.
Selected doctoral candidates will:
- carry out research across 15 academic and research institutions in 12 European countries
 - benefit from strong collaborations with biotechnology and drug discovery partners
 - engage with leading European scientific organizations, including the European Hematology Association (EHA) and the European School of Haematology (ESH)
Â
Core scientific objectives
The ACHILLES DN programme focuses on three main scientific goals:
- strengthening hemato-oncology research capacity through innovative experimental models and advanced analytical tools
 - deepening our understanding of the molecular mechanisms driving leukemia and lymphoma
 - promoting technology transfer towards targeted drugs and advanced therapies for patients with hematological malignancies
Â
Application deadline
February 28th
Full details on available positions and application procedures can be found on the official network website:
We encourage motivated students and early-career researchers interested in an international PhD experience in biomedical research to apply and help spread the word.